Category: Exchange Filings
Vancouver, Canada, January 4, 2017; Medgold Resources Corp. (TSX-V: MED) (the “Company”) announces that in accordance with the Company’s agreement to issue up to 300,000 common shares of the Company to Dan James in part consideration for his ongoing services as the Company’s President (see Medgold news release July 11, 2016), a final installment of 75,000 shares has been issued to Mr. James for services rendered during the three months ended December 31, 2016. The shares have a resale restriction which expires on May 1, 2017. About Medgold Medgold is a[…]
Written by Medgold Resources on January 4, 2017
Vancouver, Canada, October 17, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company”) announces that in accordance with the Company’s agreement to issue up to 300,000 common shares of the Company to Dan James in part consideration for his ongoing services as the Company’s President (see Medgold news release July 11, 2016), an installment of 75,000 shares has been issued to Mr. James for services rendered during the three months ended September 30, 2016. The shares have a resale restriction which expires on February 12, 2017. About Medgold Medgold is a[…]
Written by Medgold Resources on October 17, 2016
Vancouver, Canada, July 25, 2016, Medgold Resources Corp. (TSX-V: MED) announces that the TSX Venture Exchange has conditionally approved the issuance of up to 300,000 common shares of the Company to Dan James in part consideration for his ongoing services as the Company’s President (see Medgold news release July 11, 2016). The shares will be issued in installments over a one-year period commencing as of January 1, 2016. The first installment of 150,000 shares has been issued to Mr. James for services rendered during the six months ended June 30,[…]
Written by Medgold Resources on July 25, 2016
Vancouver, Canada, July 11, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce that it has entered into an option agreement to acquire up to a 100% interest in the Marrancos Project (the “Project”) located in northern Portugal. As part of its due diligence, Medgold recently completed a reconnaissance-level rock-chip sampling program. Out of 22 rock chip samples collected from across the Project license area, 14 assayed greater than 1 g/t Au. On the primary Marrancos target area, four samples were collected from both float and[…]
Written by Medgold Resources on July 11, 2016
Vancouver, Canada, June 29, 2016, Medgold Resources Corp. (TSX-V: MED) announces that it has granted incentive stock options to its directors, officers, employees and consultants to purchase up to a total of 2,580,000 shares of Medgold exercisable for ten years at a price of $0.15 per share. About Medgold Medgold is a European-focused, TSX-V listed exploration and development company targeting gold properties in northwest Iberia and the under-explored gold provinces of southern Europe. Run by a highly experienced management team with a successful track record of building value in resource companies,[…]
Written by Medgold Resources on June 29, 2016
